Literature DB >> 1860042

Periaqueductal gray stimulation produces a spinally mediated, opioid antinociception for the inflamed hindpaw of the rat.

M M Morgan1, M S Gold, J C Liebeskind, C Stein.   

Abstract

The objective of the present study was to characterize stimulation-produced antinociception from the periaqueductal gray matter (PAG) in rats with unilateral hindlimb inflammation induced by an intraplantar injection of Freund's complete adjuvant. Rats were chronically implanted with a bipolar stimulating electrode in the PAG. Nociception was assessed using a paw pressure test. Prior to inflammation, PAG stimulation significantly increased paw pressure threshold in both paws compared to non-stimulated controls. Following inflammation, PAG stimulation inhibited nociception in the inflamed, but not the non-inflamed paw. Systemic administration of naloxone blocked antinociception from ventral, but not dorsal PAG stimulation sites. Intrathecal, but not subcutaneous, administration of quaternary naltrexone completely blocked stimulation-produced antinociception from the PAG. The known increased levels of endogenous opioids occurring in the spinal cord ipsilateral to the site of inflammation suggest a mechanism for the selective antinociceptive effect of ventral PAG stimulation seen for the inflamed paw.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860042     DOI: 10.1016/0006-8993(91)91264-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

1.  Alteration of descending modulation of nociception during the course of monoarthritis in the rat.

Authors:  N Danziger; J Weil-Fugazza; D Le Bars; D Bouhassira
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

2.  Sex differences in the anatomical and functional organization of the periaqueductal gray-rostral ventromedial medullary pathway in the rat: a potential circuit mediating the sexually dimorphic actions of morphine.

Authors:  Dayna R Loyd; Anne Z Murphy
Journal:  J Comp Neurol       Date:  2006-06-10       Impact factor: 3.215

3.  Placebo effects on human mu-opioid activity during pain.

Authors:  Tor D Wager; David J Scott; Jon-Kar Zubieta
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

4.  Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce mu-opioid receptor internalization in the presence of peptidase inhibitors.

Authors:  Lijun Lao; Bingbing Song; Wenling Chen; Juan Carlos G Marvizón
Journal:  Brain Res       Date:  2008-01-03       Impact factor: 3.252

5.  N-methyl-D-aspartate receptors and large conductance calcium-sensitive potassium channels inhibit the release of opioid peptides that induce mu-opioid receptor internalization in the rat spinal cord.

Authors:  B Song; J C G Marvizón
Journal:  Neuroscience       Date:  2005-10-03       Impact factor: 3.590

6.  Activation of corticostriatal circuitry relieves chronic neuropathic pain.

Authors:  Michelle Lee; Toby R Manders; Sarah E Eberle; Chen Su; James D'amour; Runtao Yang; Hau Yueh Lin; Karl Deisseroth; Robert C Froemke; Jing Wang
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

7.  Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by mu-opioid receptor internalization.

Authors:  W Chen; J C G Marvizón
Journal:  Neuroscience       Date:  2009-03-17       Impact factor: 3.590

8.  Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptors.

Authors:  Wenling Chen; Bingbing Song; Juan Carlos G Marvizón
Journal:  Neuropharmacology       Date:  2008-02-10       Impact factor: 5.250

9.  Enkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization study.

Authors:  Juan Carlos G Marvizón; Wenling Chen; Niall Murphy
Journal:  J Comp Neurol       Date:  2009-11-01       Impact factor: 3.215

Review 10.  The neuroanatomy of sexual dimorphism in opioid analgesia.

Authors:  Dayna R Loyd; Anne Z Murphy
Journal:  Exp Neurol       Date:  2014-04-13       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.